Meanwhile, the expression of ESPL1, IQGAP3, RNASEH2A, AURKA, PRR11, PRC1, GAS2L3, CDCA8, and CEP55 was not significantly associated with the adverse prognosis of BC patients (Figure S1). This evidence concerns the gene GAS2L3 and breast cancer.